Globeflex Capital »

Black Diamond Therapeutics shares owned by Globeflex Capital

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 305k 3.79

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Onespaworld Holdings Ltd onespaworld hold (OSW)
Blue Bird Corp (BLBD)
Exelixis (EXEL)
NCR Atleos Corp (NATL)
Tenet Healthcare Corporation (THC)
Copa Holdings Sa-class A (CPA)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Universal Health Services (UHS)
Cirrus Logic (CRUS)
Ibex (IBEX)
Credicorp (BAP)
United Therapeutics Corporation (UTHR)
Medpace Hldgs (MEDP)
Marex Group (MRX)

View all positions for Globeflex Capital

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics